文献速递脑血管病外科神经重症

脑脊液乳酸和葡萄糖水平预测动脉瘤性蛛网膜下腔出血患者症状性迟发性脑缺血

Cerebrospinal Fluid Lactate and Glucose Levels as Predictors of Symptomatic Delayed Cerebral Ischemia in Patients with Aneurysmal Subarachnoid Hemorrhage.
PubMed 文献 · World Neurosurg · 2022-11-18

这项前瞻性研究纳入2020年1月至2021年12月间133例动脉瘤性蛛网膜下腔出血患者,其中48例放置脑室外引流并在早期检测脑脊液乳酸和葡萄糖。症状性迟发性脑缺血的独立预测因素包括世界神经外科医师联盟分级IV-V级、脑脊液葡萄糖升高和脑脊液乳酸升高;3个月功能结局的唯一独立预测因素是症状性迟发性脑缺血的发生。

要点

  • 世界神经外科医师联盟分级IV-V级是症状性迟发性脑缺血的独立预测因素(aOR 25.8)。
  • 脑脊液葡萄糖升高(aOR 28.8)和乳酸升高(aOR 14.7)是症状性迟发性脑缺血的独立预测因素。
  • 症状性迟发性脑缺血是3个月功能结局的唯一独立预测因素(aOR 0.02)。

核心结论

  • 动脉瘤性蛛网膜下腔出血后前3天内脑脊液乳酸和葡萄糖升高是后续迟发性脑缺血相关神经功能损害的独立预测因素。
  • 多因素校正后,器械性血管痉挛与迟发性脑缺血无显著相关。
  • 脑脊液乳酸和葡萄糖监测可能作为一种即时检验,有望改善亚急性神经功能恶化的预测并指导治疗选择。
  • 需要更大规模的前瞻性队列进一步研究。

研究设计与样本

  • 前瞻性研究,纳入2020年1月至2021年12月间所有接受脑室外引流置入并检测脑脊液乳酸和葡萄糖的动脉瘤性蛛网膜下腔出血患者。
  • 133例动脉瘤性蛛网膜下腔出血患者中,48例放置脑室外引流并进行了早期脑脊液乳酸和葡萄糖评估。

主要发现

  • 症状性迟发性脑缺血的独立预测因素为世界神经外科医师联盟分级IV-V级(aOR 25.8,95%CI 2.9-649.2,P=0.012)、脑脊液葡萄糖升高(aOR 28.8,95%CI 3.3-775.2,P=0.010)和脑脊液乳酸升高(aOR 14.7,95%CI 1.9-205.7,P=0.018)。
  • 3个月功能结局的唯一独立预测因素是症状性迟发性脑缺血的发生(aOR 0.02,95%CI 0.0-0.2,P=0.01)。
  • 多因素校正后,器械性血管痉挛与迟发性脑缺血无显著相关。

临床怎么用

  • 作者认为脑脊液乳酸和葡萄糖监测可能作为一种即时检验,有望改善亚急性神经功能恶化的预测并指导治疗选择。
  • 作者指出需要更大规模的前瞻性队列进一步研究。

局限性

  • 需要更大规模的前瞻性队列进一步研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Aneurysmal subarachnoid hemorrhage (aSAH) is a complex neurovascular syndrome with profound systemic effects associated with high rates of disability and mortality. Delayed cerebral ischemia (DCI), which encompasses all neurobiological events occurring in the subacute-late stage after aSAH, has a complex pathogenesis and can occur in the absence of instrumental vasospasm. Our aim was to assess the correlation between cerebrospinal fluid (CSF) lactate and glucose levels measured on the second or third day after aSAH with clinical deterioration caused by DCI and with 3-month functional outcome. METHODS: This prospective study included all aSAH patients admitted between January 2020 and December 2021 who underwent external ventricular drain placement and CSF lactate and glucose measurement. RESULTS: Among 133 aSAH patients, 48 had an external ventricular drain placed and early CSF lactate and glucose assessment. Independent predictors of symptomatic DCI were World Federation of Neurosurgical Societies grade IV-V (adjusted odds ratio [aOR] 25.8, 95% confidence interval [CI] 2.9-649.2, P = 0.012), elevated CSF glucose (aOR 28.8, 95% CI 3.3-775.2, P = 0.010), and elevated CSF lactate (aOR 14.7, 95% CI 1.9-205.7, P = 0.018). The only independent predictor of 3-month functional outcome was occurrence of symptomatic DCI (aOR 0.02, 95% CI 0.0-0.2, P = 0.01). CONCLUSIONS: Elevated CSF lactate and glucose levels in the first 3 days following aSAH were independent predictors of subsequent DCI-related neurological impairment; the presence of instrumental vasospasm was not significantly correlated with DCI after multivariate adjustment. CSF lactate and glucose monitoring may represent a point-of-care test, which could potentially improve prediction of subacute neurological worsening and guide therapeutic choices. Further research with larger prospective cohorts is warranted.

来源:World Neurosurg,查看原文。版权归原作者所有。

引用

  1. Messina R, de Gennaro L, De Robertis M, et al. Cerebrospinal Fluid Lactate and Glucose Levels as Predictors of Symptomatic Delayed Cerebral Ischemia in Patients with Aneurysmal Subarachnoid Hemorrhage. World Neurosurg. 2022. PMID: 36403937. doi:10.1016/j.wneu.2022.11.068

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。